Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

FORGOTTEN HISTORY: Uipath - Caught on Camera

UiPath Just Delivered 2 Bullish Signals and 1 Warning Sign for Investors

UiPath appears to be entering a more profitable phase of growth.

Barchart

UiPath Q1 Earnings Call Highlights

UiPath (NYSE:PATH) reported a stronger-than-expected start to fiscal 2027, with management highlighting growth in annual recurring revenue, revenue and profitability, as well as increasing customer adoption of its artificial intelligence and process orchestration products. Founder and Chief Executi

MarketBeat

Why is healthcare AI stuck in pilot mode? UiPath has a straightforward answer

The gap between a successful AI pilot and a fully transformed healthcare operation is often wider than many organisations expect. UiPath bridges this gap by shifting the focus from simple automation to end-to-end orchestration

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

AI Stocks Are Expensive. Is This $12 Stock the Cheapest Bet Now?

While most AI stocks look overpriced, this one is flying under the radar.

Barchart

UiPath Fell on Good News—That Could Be the Opportunity

UiPath is well-positioned to accelerate growth through AI adoption as it leans into agentic services. Client wins and retention point to strength in 2026.

MarketBeat

5 AI Stocks Positioned to Win, No Matter What

Cross-cloud operators are well-positioned for long-term strength regardless of the GPU, cloud, or provider behind the AI.

MarketBeat

The Next Market Leaders? 5 Growth Stocks to Watch in 2026

Growth and mid-cap stocks with real earnings power and improving fundamentals tend to outperform when market leadership broadens beyond mega-caps.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Dear UiPath Stock Fans, Mark Your Calendars for January 2

UiPath stock jumped after news it will join the S&P MidCap 400, a move that could reshape near-term trading dynamics and investor attention.

Barchart

UiPath Surges on Earnings: Should Investors Chase the Momentum?

UiPath has surged 36% over the prior week after beating Q3 earnings and hitting new 52-week highs, drawing fresh investor attention.

MarketBeat

Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Shares of UiPath Inc. (NYSE:PATH) rose sharply in pre-market trading after the company reported upbeat third-quarter financial results and issued fourth-quarter sales guidance with its midpoint above estimates.

Benzinga

Salesforce, Snowflake, UiPath, iRobot, And Netflix: Why These 5 Stocks Are On Investors' Radars Today

U.S. private employers unexpectedly cut 32,000 jobs in November, reversing October's gains and signaling renewed labor-market weakness. ADP's data showed broad declines led by small businesses and major sectors like manufacturing and professional services, while pay growth continued to slow. The softer report boosted market expectations for another Fed rate…

Benzinga

3 Tech Stocks That Could Dethrone the Magnificent 7

These red-hot tech stocks are growing at a rapid pace and could soon dethrone Magnificent 7 titans.

Barchart

Cramer Warns Of 'Speculative Tsunami,' Says He's Avoiding Archer Aviation Stock

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he can't recommend UiPath Inc. (NYSE:PATH) as the stock just had such a big move. “It's not for me,” he added.

Benzinga

UiPath Stock Rockets 40% on AI Agent Innovation Buzz

UiPath, Inc. (NYSE:PATH) shares climbed 40% this week on a series of major positive catalysts including new partnerships and industry recognition.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

UiPath Stock Climbs 8% Pre-Market Amid Agentic AI Push

UiPath Inc. (NYSE:PATH) saw its stock rise 7.70% in pre-market trading on Thursday, reaching $16.79.

Barchart

UiPath Is Teaming Up With Nvidia. Does That Make PATH Stock a Buy Here?

UiPath announced a new deal with Nvidia, OpenAI, Snowflake, and Alphabet.

Benzinga

OpenAI's Deal Machine Is in Overdrive—From CoreWeave To UiPath And Walmart

OpenAI's partnership engine has accelerated dramatically and is reshaping the tech, enterprise and retail landscapes at a dizzying pace.

MarketBeat

The New Brain of Business: UiPath Is Creating an AI Revolution

UiPath's strategic partnerships are embedding it as the essential orchestration layer for the future of enterprise AI and automation.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

UiPath Stock Is Surging Tuesday: What's Going On?

UiPath, Inc. (NYSE:PATH) shares are trading higher Tuesday after the company announced a partnership with OpenAI to develop ChatGPT to integrate OpenAI frontier models with enterprise customer workflows.

Barchart

Should You Buy, Sell, or Hold UiPath Stock After Q2 Earnings?

With AI and automation on the rise, can PATH survive this competitive space?

Benzinga

UiPath Shares Are Trading Higher Friday: What's Going On?

UiPath, Inc. (NYSE:PATH) shares are trading higher Friday after the company reported second quarter results above estimates and raised its fiscal year 2026 sales guidance.

Benzinga

UiPath Stock Climbs After Q2 Earnings Report: Here's Why

UiPath, Inc. (NYSE:PATH) released its second-quarter results after Thursday's closing bell. Here's a look at the details in the report.

Benzinga

DocuSign, UiPath Q2 Preview: Focus On AI Agentic Solutions

The latest CIOs survey indicates that most companies plan to "buy AI agents from app providers rather than custom building their own agents,” JPMorgan analyst Mark Murphy said in a note.

MarketBeat

3 Robotics Stocks at the Heart of the Robotics Revolution

Robotics is a logical extension of the AI revolution, these three robotics stocks bring AI-driven growth to healthcare, logistics, and enterprise software

Kiplinger

Top Tech M&A 2025: The Prospects We're Watching

High interest rates and economic uncertainty have dimmed the market for big M&A tech deals, but the tides could be turning.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Brain

12,944 stories

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.